Papers

Active cascade testing for carriers of cystic fibrosis gene

Regional Genetics Service, Royal Manchester Children's Hospital and University of Manchester, Pendlebury, Manchester M27 1HA Correspondence to: Dr Super.

Abstract

Objective : To examine the acceptability, practicability, efficiency, and application of active screening for carriers of the cystic fibrosis gene in the extended families of those in whom the disease is present (cascade screening).
Design : Paediatricians and physicians provide details of their affected patients, pedigrees are drawn up, and relatives offered tests after initial contact by the affected nuclear families. Affected patients are genotyped in a laboratory with a special interest in the genetics of cystic fibrosis.
Setting : North Western health region.
Subjects : Relatives and partners of 607 people with cystic fibrosis.
Interventions : Genetic counselling by letter for people found to be carriers; formal genetic counselling and when indicated arrangements for prenatal diagnosis for couples discovered to be carriers. Main outcome measures - Number of carrier couples detected; action in pregnancy of detected carrier couples; extent of the uptake of screening by relatives.
Results : Of 1563 relatives or partners tested, 15 carrier couples were detected; of nine pregnancies undertaken by these 15, eight had prenatal tests and three terminated pregnancies. An average of 16 people per family have come forward for testing so far.
Conclusions : Cascade screening for carriers of cystic fibrosis is well accepted by relatives, especially on the mother's side of the family; it is 10 times more efficient in detecting carrier couples than unfocused screening. Detected carrier couples make practical use of the information in pregnancy. Active cascade screening for carriers is effective in cystic fibrosis and widespread application is recommended. These principles could be applied to other recessive disorders.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    StumbleUpon    Technorati    What's this?

This article has been cited by other articles:

• Oca, F., Dreux, S., Gerard, B., Simon-Bouy, B., de Becdelievre, A., Ferec, C., Girodon, E., Muller, F. (2009). Amniotic Fluid Digestive Enzyme Analysis Is Useful for Identifying CFTR Gene Mutations of Unclear Significance. Clin. Chem. 55: 2214-2217 [Abstract] [Full text]  
• Coates, N., Gregory, M., Skirton, H., Gaff, C., Patch, C., Clarke, A., Parsons, E. (2007). Family communication about cystic fibrosis from the mother's perspective: an exploratory study. Journal of Research in Nursing 12: 619-634 [Abstract]  
• Super, M., Irtiza-Ali, A., Roberts, S. A., Schwarz, M., Young, M., Smith, A., Roberts, T., Hinks, J., Heagerty, A. (2004). Blood Pressure and the Cystic Fibrosis Gene: Evidence for Lower Pressure Rises With Age in Female Carriers. Hypertension 44: 878-883 [Abstract] [Full text]  
• King, P T, Freezer, N J, Holmes, P W, Holdsworth, S R, Forshaw, K, Sart, D D (2004). Role of CFTR mutations in adult bronchiectasis. Thorax 59: 357-358 [Full text]  
• Super, M (2003). Cystic fibrosis newborn screening and detection of carriers. Arch. Dis. Child. Fetal Neonatal Ed. 88: F448-449 [Full text]  
• Super, M., Barnes, R., Greig, D. (2001). Failure to refer for testing for cystic fibrosis. BMJ 322: 310-311 [Full text]  
• Castaldo, G., Fuccio, A., Cazeneuve, C., Picci, L., Salvatore, D., Raia, V., Scarpa, M., Goossens, M., Salvatore, F. (1999). Detection of Five Rare Cystic Fibrosis Mutations Peculiar to Southern Italy: Implications in Screening for the Disease and Phenotype Characterization for Patients with Homozygote Mutations. Clin. Chem. 45: 957-962 [Abstract] [Full text]  
• Malats, N., Real, F. X., Sharer, N. M., Schwartz, M. J. (1999). Correction: Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis. NEJM 340: 1592-1593 [Full text]  
• Sharer, N., Schwarz, M., Malone, G., Howarth, A., Painter, J., Super, M., Braganza, J. (1998). Mutations of the Cystic Fibrosis Gene in Patients with Chronic Pancreatitis. NEJM 339: 645-652 [Abstract] [Full text]  
• Cuckle, H S, Richardson, G A, Sheldon, T A, Quirke, P (1995). Cost effectiveness of antenatal screening for cystic fibrosis. BMJ 311: 1460-1460 [Abstract] [Full text]  
• Cooper, J D A, Franks, A J, Brock, D J H, Quereshi, N (1994). Screening for cystic fibrosis Screening before pregnancy is preferred. BMJ 309: 339-340 [Full text]  
• (1994). SCREENING FOR CYSTIC FIBROSIS ASSESSED. JWatch General 1994: 1-1 [Full text]  
• Raeburn, S (1994). Screening for carriers of cystic fibrosis. BMJ 308: 1451-1452 [Full text]